Apo-Linezolid · DIN 02426552 · 600 mg · tablet
Limited Use, Reason for Use code 362, 363, 364 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 362, 363, 364 required
Write on scriptone applicable Reason for Use code, 362 or 363 or 364 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 362, 363, 364
Coverage limit:
For the treatment of patients with:
Reason for Use code 362
Methicillin-resistant Staphylococcus species (MRSA, MRSE) infections* in patients who are intolerant or have failed vancomycin therapy, or have contraindications to venous access.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 363
Vancomycin resistant Enterococcus species (VRE) infections* in patients switching from IV linezolid.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 364
Step-down therapy for the treatment of methicillin-resistant Staphylococcus species or vancomycin resistant Enterococcus species (VRE) infections* after parenteral therapy or hospital/ emergency department discharge.
Coverage limit:
* Infections must be documented and culture proven. Not approved for colonization (e.g. nares, urine, etc). Maximum 28 days supply.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Apo-Linezolid · DIN 02426552
Manufacturer: Apotex Inc.; listing date 2014-10-29
Health Canada: Marketed since 2019-10-31 · brand APO-LINEZOLID · ATC J01XX08 LINEZOLID · form Tablet · route Oral · ingredients LINEZOLID 600 MG · company Apotex inc · schedule Prescription
Apo-Linezolid: Formulary list price $19.30 per unit (the source does not state the unit; exact figure $19.3041). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02426552)
Source record
DIN 02426552: Apo-Linezolid
Raw flags: sec12=Y, sec3=Y
Item: 084000054; group id 136; item number 0229; lccId 00014; manufacturer id APX
Source form: Tab; strength: 600mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $19.3041; ministry $19.3041
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02426552
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=91113
Interchangeable products
Jamp Linezolid · DIN 02520354 · $19.3041
Sandoz Linezolid · DIN 02422689 · $19.3041
Zyvoxam · DIN 02243684 · not recorded
Shortage status: not checked (no credentials)